Clinical Trials Logo

Clinical Trial Summary

Study to evaluate the safety and performance of a new blister patch intended to treat blisters on the heel of the foot.


Clinical Trial Description

The study will require participation for up to 14 days of participation or less if the blister heals sooner, will recruit 100 subjects with fluid filled blisters on the heel of the foot that are intact and not broken. Some subjects will be asked to have their blisters photographed. All subjects will be required to have their blister unroofed (top layer of skin removed by the physician using sterile instruments). All subjects will receive study product, either test product or a marketed product. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01088685
Study type Interventional
Source Johnson & Johnson Consumer and Personal Products Worldwide
Contact
Status Completed
Phase N/A
Start date March 2010
Completion date November 2010

See also
  Status Clinical Trial Phase
Completed NCT04308889 - Pro-Resolving Mediators in Acute Inflammation in Humans Early Phase 1
Completed NCT02810002 - Assessing Foot Injuries in Infantry Recruits Wearing Different Boots Phase 1/Phase 2
Completed NCT05378997 - Safety, Tolerability, and Pharmacokinetics of Ascending Topical Doses of TCP-25 Applied to Epidermal Suction Blister Wounds, Non-Healing Leg Ulcers and Patients With Dystrophic Epidermolysis Bullosa. Phase 1
Completed NCT01120808 - Prevention Trial Assessing Paper-Tape in Endurance Distances (PreTAPED) Phase 1